PharmaCyte Biotech Inc (PMCB) support and resistance · $8.6M cap
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
This page maps PharmaCyte Biotech Inc (PMCB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
PMCB currently screens at market cap $8.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PMCB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PMCB quote page for the session range and the stock page for the full model.
Not investment advice.